AHNAK Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant AHNAK.
|Application ||WB, IP, E|
|Calculated MW||629101 Da|
|Other Names||Neuroblast differentiation-associated protein AHNAK, Desmoyokin, AHNAK, PM227|
|Target/Specificity||AHNAK (NP_076965, 1 a.a. ~ 100 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||AHNAK Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1.Proteomic investigation of the interactome of FMNL1 in hematopoietic cells unveils a role in calcium-dependent membrane plasticity.Han Y, Yu G, Sarioglu H, Caballero-Martinez A, Schlott F, Ueffing M, Haase H, Peschel C, Krackhardt AM.J Proteomics. 2012 Nov 24. pii: S1874-3919(12)00756-7. doi: 10.1016/j.jprot.2012.11.015.2.Ahnak1 interaction is affected by phosphorylation of Ser-296 on Cav?]2.Pankonien I, Otto A, Dascal N, Morano I, Haase H.Biochem Biophys Res Commun. 2012 Apr 4. [Epub ahead of print]3.Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle release.Zacharias U, Purfurst B, Schowel V, Morano I, Spuler S, Haase H.J Muscle Res Cell Motil. 2011 Nov 5. [Epub ahead of print]4.The C type natriuretic peptide receptor tethers AHNAK1 at the plasma membrane to potentiate arachidonic acid induced calcium mobilization.Alli AA, Gower WR Jr.Am J Physiol Cell Physiol. 2009 Aug 26. [Epub ahead of print]5.Searching for new biomarkers of bladder cancer based on proteomic analysis.Okusa H, Kodera Y, Oh-Ishi M, MinamidaY, Tsuchida M, Kavoussi N, Matsumoto K, Sato T, Iwamura M, Maeda Y, Baba S.J Electrophoresis 2008 ; 52 : 19
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.